Welcome to Helix Talk, a podcast presented by the Rosalm Franklin University College of Pharmacy.

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics.

We're hoping that our real-life clinical pearls and discussions will help you stay up to date

and improve your pharmacy knowledge.

This is an educational production, copyright Rosalind Franklin University of Medicine and Science.

This podcast contains general information for educational purposes only. This is not professional advice and should not be used in lieu of obtaining advice from a qualified health care provider.

And now, on to the show.

Welcome to episode 15 of Helix Talk. I'm your co-host, Dr. Kane.

I'm Dr. Hartranft. And I'm Dr. Schumann.

We're missing Dr. Patel today.

But today we're talking about cancer screening.

And that's why we have Dr. Hartranft on the show today to discuss that.

She would be the content expert at the university.

And I'm pleased to be here to participate.

So why are you passionate about this topic?

What is it about cancer screening that you think is particularly relevant to patients

and probably commonly what you'll get questioned on by patients?

Well, it's something that every patient has, every patient sees.

You know, not every patient is going to develop cancer in their lifetime. In fact,

very few people really will when we think about it in the global scheme of things. But many patients,

all patients really, are eventually going to need to be screened for cancer. It's something we're all at

risk for, even if we don't all develop it. And so I personally do get a lot of questions about

...